AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Inclusion of cancer drug in WHO Covid Solidarity trial: CDSCO panel asks ICMR to submit more clarification Farhat Nasim19 Oct 2020 5:14 PM ISTNew Delhi: The expert panel of the Central Drugs Standard Control Organisation (CDSCO) has recently asked the apex medical research body, Indian...
AstraZeneca to launch cancer drug Acalabrutinib under brand name Calquence Ruchika Sharma16 Oct 2020 11:25 AM ISTNew Delhi: Drug firm AstraZeneca Pharma India on Thursday said it will launch its Acalabrutinib 100 mg capsules, used for treatment of various types...
